1.
Exploring the Potential of Drug Repurposing: Detection of Cystic Fibrosis Transmembrane Conductance Regulator as a Biomarker in Breast Cancer Patients. Precis. Med. Com. 2023;3(1):11-26. doi:10.55627/pmc.003.01.0300